Cell Source, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
NV
Business Address
57 WEST 57TH STREET, NEW YORK, NY, 10019
Mailing Address
57 WEST 57TH STREET, NEW YORK, NY, 10019
Phone
646-612-7554
Fiscal Year End
1231
EIN
320379665
Financial Overview
FY2017
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | April 7, 2026 | View on SEC |
| 8-K Current report of material events | June 27, 2025 | View on SEC |
Annual Reports
10-K
April 7, 2026
- Developing innovative 'Veto Cell' technology to improve bone marrow transplant safety.
- Potential to create an 'off-the-shelf' cancer treatment by combining Veto Cells with CAR-T therapies.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.